Business · 17/06/2015Updated: 10/17/2026 · 1 min read
FDA Publishes Guidance on Naming of Drug Products Containing Salt Drug Substances
Summary
The FDA has released a new guidance document, replacing a previous draft, which outlines the USP's naming policy for salt drug substances in pharmaceuticals and how the CDER will implement it, following its adoption on May 1, 2013.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →